The Personalized Medicine Approaches in the Treatment of Corona Virus Disease-۲۰۱۹ (COVID-۱۹): A Review

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 143

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PMJ-7-25_003

تاریخ نمایه سازی: 8 مرداد 1401

Abstract:

Personalized medicine is the clinical treatment of diseases that is tailored to the physiologic, molecular genetics and lifestyle characteristics of the patient.Personalized medicine can be considered as a new approach to face diseases and develop traditional methods for their diagnosis and treatment. This novel field of medicine has the potential of changing identification and management of health problems strategies. Corona virus disease ۲۰۱۹ (COVID-۱۹) is an infectious disease that affects the lungs of patients. This novel outbreak was first reported on ۳۱ December ۲۰۱۹ in Wuhan, the capital of Hubei province of China, and it had many effects on people's lives all over the world in various economic, social and health fields until now. Since the start of the pandemic Covid-۱۹, the World Health Organization (WHO) has expressed concern about the public health emergency. Although the disease has mild symptoms and similar to a common cold in most people, in some cases it can lead to pneumonia, acute respiratory distress syndrome, multi-organ dysfunction, and even death. Therefore, due to the different effects of this disease in individuals and even families, the role of personalized medicine becomes more significant and sensitive. Considering the rapid spread and global crisis of Covid-۱۹, recent research has focused more on the control and treatment of the virus. The main goal of this paper is the investigation of different effects of the virus on patients and study of the personalized medicine roles in the control and treatment of the disease.

Keywords:

Personalized Medicine , COVID-۱۹ , Corona Virus , Angiotensin-converting enzyme ۲ (ACE۲)

Authors

Homeira Zare Chavoshy

۱Department of Nanotechnology, Jabir Ibn Hayyan Institute, Technical and Vocational Training Organization, Isfahan, Iran

Razieh Ghasemi

۱Department of Nanotechnology, Jabir Ibn Hayyan Institute, Technical and Vocational Training Organization, Isfahan, Iran